Cook Meredith (CIK 1938861) reported 26 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-13). Recent activity: Sell ANIP (500 shares), Sell ANIP (500 shares), Sell ANIP (500 shares), Buy ANIP (13,895 shares), Sell ANIP (1,555 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $39,080 |
| 2026-04-13 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $38,975 |
| 2026-03-13 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $36,310 |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Buy | 13,895 | $1.1M |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 1,555 | $114,914 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 1,534 | $117,658 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $38,400 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 1,779 | $137,623 |
| 2026-02-13 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 3,011 | $229,589 |
| 2026-01-14 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $42,165 |
| 2025-12-12 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $32,928 |
| 2025-11-14 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $34,908 |
| 2025-10-14 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $36,036 |
| 2025-09-15 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $39,368 |
| 2025-08-14 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $35,548 |
| 2025-07-21 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 2,071 | $137,307 |
| 2025-07-14 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $25,952 |
| 2025-06-16 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $24,548 |
| 2025-05-13 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $24,880 |
| 2025-04-14 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $27,584 |
| 2025-03-14 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $25,332 |
| 2025-03-04 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 1,099 | $68,017 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Buy | 16,974 | $0 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Buy | 11,316 | $0 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | SR. VP, GENERAL COUNSEL & SEC. | Sell | 400 | $23,816 |
Source: SEC Form 4 filings · as of 2026-05-13